Transchem

31
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE019B01010
  • NSEID:
  • BSEID: 500422
INR
122.11
5.81 (5.0%)
BSENSE

Dec 05

BSE+NSE Vol: 43.62 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'20
Mar'19
Mar'18
Mar'17
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 541.56% vs NA in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 15.67% vs NA in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 24.33% vs NA in Mar 2024

Compare Profit and Loss Results of Transchem
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
2.00
116.00
-114.00
-98.28%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
2.00
116.00
-114.00
-98.28%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-8.00
8.00
100.00%
Raw Materials Consumed
2.00
60.00
-58.00
-96.67%
Power & Fuel Cost
0.00
10.00
-10.00
-100.00%
Employee Cost
0.00
12.00
-12.00
-100.00%
Operating Expenses
0.00
14.00
-14.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
4.00
-4.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
2.00
-2.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
4.00
99.00
-95.00
-95.96%
Operating Profit (PBDIT) excl Other Income
-1.00
16.00
-17.00
-106.25%
Other Income
8.00
1.00
7.00
700.00%
Operating Profit (PBDIT)
7.00
18.00
-11.00
-61.11%
Interest
0.00
6.00
-6.00
-100.00%
Profit before Depriciation and Tax
7.00
12.00
-5.00
-41.67%
Depreciation
0.00
5.00
-5.00
-100.00%
Profit Before Taxation & Exceptional Items
7.00
6.00
1.00
16.67%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
7.00
6.00
1.00
16.67%
Provision for Tax
1.00
1.00
0.00
0.00%
Profit After Tax
5.00
5.00
0.00
0.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
42.00
20.00
22.00
110.00%
Profit Available for appropriations
47.00
25.00
22.00
88.00%
Appropriations
47.00
25.00
22.00
88.00%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
4.27
4.1
0.17
4.15%
Profit And Loss - Net Sales
Net Sales 2.63 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 541.56% vs NA in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -1.46 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 15.67% vs NA in Mar 2024

Profit And Loss - Interest
Interest 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 5.23 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 24.33% vs NA in Mar 2024